Locally Advanced Pancreatic Adenocarcinoma trials recruiting in Michigan

All Locally Advanced Pancreatic Adenocarcinoma trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
  NCT07157033 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
  NCT06850623 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
  NCT06673017 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Battle Creek, Escanaba, Grand Rapids, Kalamazoo
• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04172532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit, Farmington Hills